• Home
  • Company
    • Mission
    • Management Team
    • Locations
    • Investors
    • Awards
  • Products
    • Product Overview
    • Bafasal®
    • Bafador®
    • Product Pipeline
  • Strategy
    • Strategic Goals
  • Partnering
    • Co-Development
    • Become a Distributor
    • Grants
  • Sustainability
    • Sustainability Overview
    • Reports
  • Media
    • Events & Presentations
    • News
  • COVID-19
  • Contact
Addressing_superbug_concern
May 27, 2020

Addressing_superbug_concern

Michal Stepien

Addressing the Superbug Concern: Phage Therapy Could Beat Drug Resistant Illnesses

Categories

  • Company News (16)
  • Proteon General News (1)

Recent Posts

  • Proteon Pharmaceuticals – strategiczne partnerstwo handlowe z DuPont Animal Nutrition
  • Proteon Pharmaceuticals announces a strategic partnership in distribution with DuPont Animal Nutrition
  • Addressing the Superbug Concern: Phage Therapy Could Beat Drug Resistant Illnesses
  • Proteon Pharmaceuticals Joins Research Efforts to Fight Coronavirus
  • Proteon Pharmaceuticals włącza się w walkę z koronawirusem

Our Solutions

170131_salmonellafree_logo_456x181-e1486970860523

Contact Proteon

Follow Us —

Company

  • Mission
  • Management Team
  • Locations
  • Investors
  • Awards

Products

  • Product Overview
  • Bafasal®
  • Bafador®
  • Product Pipeline

Partnering

  • Co-Development
  • Become a Distributor
  • Grants

Strategy

  • Strategic Goals

Sustainability

  • Overview
  • Reports

Media

  • Events & Presentations
  • Media About Us
  • News
logo_proteon-white

CUSTOMER SERVICE:    +48 502-678-674     |     proteon@proteonpharma.com

Privacy Policy | Polityka Prywatności

Copyright © 2019 Proteon Pharmaceuticals, All Rights Reserved